186 related articles for article (PubMed ID: 38171190)
1. Long-term second primary cancer risk in adolescent and young adult (15-39 years) cancer survivors: a population-based study in the Netherlands between 1989 and 2018.
van der Meer DJ; van der Graaf WTA; van de Wal D; Karim-Kos HE; Husson O
ESMO Open; 2024 Jan; 9(1):102203. PubMed ID: 38171190
[TBL] [Abstract][Full Text] [Related]
2. Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (Teenage and Young Adult Cancer Survivor Study): a population-based, cohort study.
Bright CJ; Reulen RC; Winter DL; Stark DP; McCabe MG; Edgar AB; Frobisher C; Hawkins MM
Lancet Oncol; 2019 Apr; 20(4):531-545. PubMed ID: 30797674
[TBL] [Abstract][Full Text] [Related]
3. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
4. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
5. Excess risk of subsequent malignant neoplasms in adolescent and young adult cancer survivors: Results from the first Italian population-based cohort.
Trama A; Tittarelli A; Barigelletti G; Botta L; Gatta G; Tagliabue G; Contiero P; Guzzinati S; Andreano A; Manneschi G; Falcini F; Castaing M; Filiberti RA; Gasparotti C; Cirilli C; Mazzucco W; Mangone L; Iacovacci S; Vitale MF; Stracci F; Piffer S; Tumino R; Carone S; Sampietro G; Melcarne A; Ballotari P; Boschetti L; Pisani S; Cavalieri D'Oro L; Cuccaro F; D'Argenzio A; D'Orsi G; Fanetti AC; Ardizzone A; Candela G; Savoia F; Pascucci C; Castelli M; Storchi C; Bernasconi A
Cancer; 2022 Jan; 128(2):364-372. PubMed ID: 34582036
[TBL] [Abstract][Full Text] [Related]
6. Increased risk of second malignant neoplasms in adolescents and young adults with cancer.
Lee JS; DuBois SG; Coccia PF; Bleyer A; Olin RL; Goldsby RE
Cancer; 2016 Jan; 122(1):116-23. PubMed ID: 26441212
[TBL] [Abstract][Full Text] [Related]
7. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML
Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718
[TBL] [Abstract][Full Text] [Related]
8. Cancer in adolescents and young adults (15-29 years): a population-based study in the Netherlands 1989-2009.
Aben KK; van Gaal C; van Gils NA; van der Graaf WT; Zielhuis GA
Acta Oncol; 2012 Sep; 51(7):922-33. PubMed ID: 22934554
[TBL] [Abstract][Full Text] [Related]
9. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
[TBL] [Abstract][Full Text] [Related]
10. Cause-specific mortality in survivors of adolescent and young adult cancer.
Armenian SH; Xu L; Cannavale KL; Wong FL; Bhatia S; Chao C
Cancer; 2020 May; 126(10):2305-2316. PubMed ID: 32129881
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
Teepen JC; van Leeuwen FE; Tissing WJ; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; Neggers SJCMM; Jaspers MWM; Hauptmann M; van der Heiden-van der Loo M; Visser O; Kremer LCM; Ronckers CM;
J Clin Oncol; 2017 Jul; 35(20):2288-2298. PubMed ID: 28530852
[TBL] [Abstract][Full Text] [Related]
12. Endocrine Late Effects in Survivors of Cancer in Adolescence and Young Adulthood: A Danish Population-Based Cohort Study.
Jensen MV; Rugbjerg K; de Fine Licht S; Johansen C; Schmiegelow K; Andersen KK; Winther JF
JAMA Netw Open; 2018 Jun; 1(2):e180349. PubMed ID: 30646084
[TBL] [Abstract][Full Text] [Related]
13. Risks of subsequent primary cancers among breast cancer survivors according to hormone receptor status.
Sung H; Freedman RA; Siegel RL; Hyun N; DeSantis CE; Ruddy KJ; Jemal A
Cancer; 2021 Sep; 127(18):3310-3324. PubMed ID: 34002851
[TBL] [Abstract][Full Text] [Related]
14. Risk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe: A cohort study within PanCareSurFup.
Allodji RS; Hawkins MM; Bright CJ; Fidler-Benaoudia MM; Winter DL; Alessi D; Fresneau B; Journy N; Morsellino V; Bárdi E; Bautz A; Byrne J; Feijen ELA; Teepen JC; Vu-Bezin G; Rubino C; Garwicz S; Grabow D; Gudmundsdottir T; Guha J; Hau EM; Jankovic M; Kaatsch P; Kaiser M; Linge H; Muraca M; Llanas D; Veres C; Øfstaas H; Diallo I; Mansouri I; Ronckers CM; Skinner R; Terenziani M; Wesenberg F; Wiebe T; Sacerdote C; Jakab Z; Haupt R; Lähteenmäki P; Zaletel LZ; Kuehni CE; Winther JF; Michel G; Kremer LCM; Hjorth L; Haddy N; de Vathaire F; Reulen RC
Eur J Cancer; 2019 Aug; 117():71-83. PubMed ID: 31260818
[TBL] [Abstract][Full Text] [Related]
15. Long-term risks of subsequent primary neoplasms among survivors of childhood cancer.
Reulen RC; Frobisher C; Winter DL; Kelly J; Lancashire ER; Stiller CA; Pritchard-Jones K; Jenkinson HC; Hawkins MM;
JAMA; 2011 Jun; 305(22):2311-9. PubMed ID: 21642683
[TBL] [Abstract][Full Text] [Related]
16. Second primary cancers in survivors of cervical cancer in The Netherlands: Implications for prevention and surveillance.
Arnold M; Liu L; Kenter GG; Creutzberg CL; Coebergh JW; Soerjomataram I
Radiother Oncol; 2014 Jun; 111(3):374-81. PubMed ID: 24833558
[TBL] [Abstract][Full Text] [Related]
17. Incidence, Risk Factors, and Mortality Associated With Second Malignant Neoplasms Among Survivors of Adolescent and Young Adult Cancer.
Chao C; Bhatia S; Xu L; Cannavale KL; Wong FL; Huang PS; Cooper R; Armenian SH
JAMA Netw Open; 2019 Jun; 2(6):e195536. PubMed ID: 31173129
[TBL] [Abstract][Full Text] [Related]
18. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
Travis LB; Hill D; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Pukkala E; Lynch CF; Pee D; Smith SA; Van't Veer MB; Joensuu T; Storm H; Stovall M; Boice JD; Gilbert E; Gail MH
J Natl Cancer Inst; 2005 Oct; 97(19):1428-37. PubMed ID: 16204692
[TBL] [Abstract][Full Text] [Related]
19. Risk of second primary cancer among women in the Kaiser Permanente Breast Cancer Survivors Cohort.
Ramin C; Veiga LHS; Vo JB; Curtis RE; Bodelon C; Aiello Bowles EJ; Buist DSM; Weinmann S; Feigelson HS; Gierach GL; Berrington de Gonzalez A
Breast Cancer Res; 2023 May; 25(1):50. PubMed ID: 37138341
[TBL] [Abstract][Full Text] [Related]
20. Risk of second primary in situ and invasive melanoma in a Dutch population-based cohort: 1989-2008.
van der Leest RJ; Liu L; Coebergh JW; Neumann HA; Mooi WJ; Nijsten T; de Vries E
Br J Dermatol; 2012 Dec; 167(6):1321-30. PubMed ID: 22759226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]